Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

A newly published evidence-based guideline offers 18 recommendations to improve how clinicians diagnose and treat nocturnal enuresis (bedwetting) in children. Developed using the Delphi method with 42 multidisciplinary experts, the guidelines update diagnostic criteria and emphasize individualized treatment. First-line options include desmopressin for nocturnal polyuria and alarm therapy for reduced bladder capacity.
A new consensus guideline published in the World Journal of Pediatrics aims to bring consistency and personalization to the diagnosis and management of childhood nocturnal enuresis (NE)—commonly known as bedwetting. Developed by a nine-member writing group led by researchers at the Children's Hospital of Fudan University in Shanghai, the guideline used the Delphi method, with 42 multidisciplinary panelists voting iteratively to reach consensus on 18 key recommendations.
The updated diagnostic criteria now include children aged 5 and older who experience at least one involuntary void per month over three months. A key emphasis is placed on classifying NE as either monosymptomatic or nonmonosymptomatic (NMNE) based on daytime lower urinary tract symptoms, which helps guide treatment decisions. Clinicians are also advised to have families maintain a voiding diary—at least two days of daytime records and seven consecutive nights—to determine enuresis subtype.
Key Takeaways:
Why it matters: Bedwetting affects millions of children worldwide and can significantly impact quality of life. Standardized, evidence-based guidelines help ensure children receive timely, appropriate, and individualized care.